24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Principle of Sovereign Immunity
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:28
Amazon’s CISO: Slowing software releases can make you less secure
09:50
Remepy CEO: "We're entering Phase 3 in Parkinson's disease"
09:50
ROOMS by Fattal CEO on making reserve duty founders a core company value
09:50
"We are very, very good at applied AI"
More stories
Buzz
Most popular
Daily
Weekly
1
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
2
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
3
Israeli startup Coldi is deploying AI agents to take over the cold call
4
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
5
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
More news
Principle of Sovereign Immunity
1 stories about Principle of Sovereign Immunity
Court Rules Allergan Can't Use Indian Tribe Deal to Protect Patents
23.07.18
|
CTech
In September 2017, Allergan transferred six of its patents for blockbuster dry eye drug Restasis to the St. Regis Mohawk Tribe, hoping to protect the patents under the principle of sovereign immunity
